Top Healthcare companies in Switzerland by Price to Sales Ratio (P/S)

This ranking features the top 24 Healthcare companies in Switzerland ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 4.74, for February 06, 2025.
#
Name
Price to Sales Ratio (P/S)
Reported Date
Stock Price
Change
Price (30 days) Country
1

23.01

Feb. 3, 2025 USD 24.30 -3.46%

Switzerland

2

22.23

Feb. 3, 2025 USD 5.05 -4.17%

Switzerland

3

8.59

Feb. 3, 2025 USD 382.54 -3.00%

Switzerland

4

7.73

Feb. 3, 2025 USD 138.90 -2.86%

Switzerland

5

6.83

Feb. 3, 2025 USD 62.45 -2.60%

Switzerland

6

6.49

Feb. 3, 2025 USD 651.30 2.02%

Switzerland

7

4.47

Feb. 3, 2025 USD 126.21 -1.33%

Switzerland

8

4.02

Feb. 3, 2025 USD 74.55 -2.22%

Switzerland

9

4.00

Feb. 3, 2025 USD 104.72 -0.12%

Switzerland

10

3.52

Feb. 3, 2025 USD 333.72 0.27%

Switzerland

11

3.23

Feb. 3, 2025 USD 1.12 K -0.26%

Switzerland

12

2.83

Feb. 3, 2025 USD 43.76 -1.99%

Switzerland

13

2.55

Feb. 3, 2025 USD 27.36 -2.78%

Switzerland

14

2.52

Feb. 3, 2025 USD 250.45 -3.26%

Switzerland

15

2.20

Feb. 3, 2025 USD 161.30 -1.97%

Switzerland

16

2.03

Feb. 3, 2025 USD 46.21 -3.47%

Switzerland

17

1.76

Feb. 3, 2025 USD 17.87 -4.83%

Switzerland

18

1.25

Feb. 3, 2025 USD 60.16 -1.72%

Switzerland

19

1.20

Feb. 3, 2025 USD 15.53 -0.65%

Switzerland

20

1.00

Feb. 3, 2025 USD 88.99 -0.28%

Switzerland

21

0.94

Feb. 3, 2025 USD 13.36 -0.81%

Switzerland

22

0.87

Feb. 3, 2025 USD 1.14 K -1.12%

Switzerland

23

0.36

Feb. 3, 2025 USD 3.57 -5.82%

Switzerland

24

0.16

Feb. 3, 2025 USD 21.72 -0.35%

Switzerland

Frequently Asked Questions
  • Which Healthcare company in Switzerland has the highest Price to Sales Ratio (P/S) ?

    The Healthcare company in Switzerland with the highest Price to Sales Ratio (P/S) is Kuros Biosciences AG (Swiss Stock Exchange: KURN.SW) at 23.01.

  • Which Healthcare company in Switzerland has the lowest Price to Sales Ratio (P/S) ?

    The Healthcare company in Switzerland with the lowest Price to Sales Ratio (P/S) is DocMorris AG (LSE: 0RRB.L) at 0.16.

SV Wall Street